| 臺大學術典藏 |
2021-03-18T08:54:19Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:18Z |
One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry
|
Chang H.-Y.; Wang C.-C.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H. |
| 臺大學術典藏 |
2021-03-18T08:54:17Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:15Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; Tsai C.-T.; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Cheng H.-M.; Shin S.-J.; Huang C.-N.; Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L. |
| 臺大學術典藏 |
2021-03-18T08:54:15Z |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Chen K.-C.; Yin W.-H.; Wu C.-C.; Chan S.-H.; YEN-WEN WU; Wang K.Y.; Chang K.-C.; Hwang J.-J.; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chiang C.-E.; Lei M.-H.; Lin J.-F.; Shyu K.-G. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
Relationship between body mass index, antidiabetic agents, and midterm mortality in patients with both type 2 diabetes mellitus and acute coronary syndrome
|
Jong C.-B.; Li H.-Y.; Pan S.-L.; Hsieh M.-Y.; Su F.-Y.; Chen K.-C.; Yin W.-H.; Chan S.-H.; YEN-WEN WU; Wang K.-Y.; Chang K.-C.; Hwang J.-J.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:09Z |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:08Z |
2019 focused update of the guidelines of the Taiwan society of cardiology for the diagnosis and treatment of heart failure
|
Wang C.-C.; Wu C.-K.; Tsai M.-L.; Lee C.-M.; Huang W.-C.; Chou H.-H.; Huang J.-L.; Chi N.-H.; Yen H.-W.; Tzeng B.-H.; Chang W.-T.; Chang H.-Y.; Wang C.-H.; Lu Y.-Y.; Tsai J.-P.; Su C.-H.; Cherng W.-J.; Yin W.-H.; Tsai C.-T.; YEN-WEN WU; Lin J.-L.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:08Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:05Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:05Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:02Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:01Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 國立成功大學 |
2021 |
Fasting triglycerides is a risk factor for cardiovascular event in T-SPARCLE registry in Taiwan
|
Chen, Chen C.-Y.;Tseng, W.-K.;Lin, F.-J.;Wu, Y.-W.;Lin, T.-H.;Li, Y.-H.;Sheu, W.H.-H.;Huang, L.-C.;Hsieh, I.C.;Pan, W.-H.;Yeh, H.I.;Wu, C.-C.;Yin, W.-H.;Chen, J.-W. |
| 國立成功大學 |
2021 |
2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J.;Hou, C.J.-Y. |
| 臺大學術典藏 |
2020-12-30T08:47:37Z |
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
|
Wen M.-S.; Cheng C.-C.; Chen Y.-J.; Chen M.-C.; Wang K.-L.; Lin L.-Y.; Chiang C.-E.; Wu T.-J.; Ueng K.-C.; Chao T.-F.; Chang K.-C.; Wang C.-C.; Lin Y.-J.; Yin W.-H.; Kuo J.-Y.; Lin W.-S.; CHIA-TI TSAI; Liu Y.-B.; Lee K.-T.; Lin L.-J.; Chen W.-J.; Chen J.-H.; Lai W.-T.; Chiou C.-W.; Lin J.-L.; Yeh S.-J.; Chen S.-A. |
| 臺大學術典藏 |
2020-12-30T08:47:34Z |
2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chuang L.-M.; Lin S.-J.; Yeh S.-J.; Sheu W.H.-H.; Lin J.-L.; Chiang C.-E.; Lin S.-Y.; Lin T.-H.; Wang T.-D.; Yeh H.-I.; Chen J.-F.; CHIA-TI TSAI; Hung Y.-J.; Li Y.-H.; Liu P.-Y.; Chang K.-C.; Wang K.-L.; Chao T.-H.; Shyu K.-G.; Yang W.-S.; Ueng K.-C.; Chu P.-H.; Yin W.-H.; Wu Y.-W.; Cheng H.-M.; Shin S.-J.; Huang C.-N. |
